These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


187 related items for PubMed ID: 21131830

  • 1. Immunohistochemical characteristics of atypical polypoid adenomyoma with special reference to h-caldesmon.
    Horita A, Kurata A, Maeda D, Fukayama M, Sakamoto A.
    Int J Gynecol Pathol; 2011 Jan; 30(1):64-70. PubMed ID: 21131830
    [Abstract] [Full Text] [Related]

  • 2. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
    Ohishi Y, Kaku T, Kobayashi H, Aishima S, Umekita Y, Wake N, Tsuneyoshi M.
    Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
    [Abstract] [Full Text] [Related]

  • 3. Stromal p16 Expression Helps Distinguish Atypical Polypoid Adenomyoma From Myoinvasive Endometrioid Carcinoma of the Uterus.
    Kihara A, Amano Y, Yoshimoto T, Matsubara D, Fukushima N, Fujiwara H, Niki T.
    Am J Surg Pathol; 2019 Nov; 43(11):1526-1535. PubMed ID: 31600177
    [Abstract] [Full Text] [Related]

  • 4. Stromal p16 and SATB2 Expression Does Not Distinguish Atypical Polypoid Adenomyoma (APA) From its Benign Mimics.
    Bui CM, Azimpouran M, Balzer B, Maluf H, Medeiros F.
    Int J Gynecol Pathol; 2024 Nov 01; 43(6):586-594. PubMed ID: 38833724
    [Abstract] [Full Text] [Related]

  • 5. Immunophenotype of Atypical Polypoid Adenomyoma of the Uterus: Diagnostic Value and Insight on Pathogenesis.
    Travaglino A, Raffone A, Saccone G, Fuggi M, De Placido G, Mascolo M, Mollo A, Insabato L, Zullo F.
    Appl Immunohistochem Mol Morphol; 2020 Sep 01; 28(8):646-653. PubMed ID: 31855579
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Atypical polypoid adenomyoma of the uterus: an immunohistochemical study on 5 cases.
    Terada T.
    Ann Diagn Pathol; 2011 Oct 01; 15(5):338-41. PubMed ID: 21684185
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A, Ji H, Shih IeM, Wang TL, Wu LS, Ronnett BM.
    Am J Surg Pathol; 2009 Oct 01; 33(10):1504-14. PubMed ID: 19623034
    [Abstract] [Full Text] [Related]

  • 12. Uterine adenosarcomas: diagnostic use of the proliferation marker Ki-67 as an adjunct to morphologic diagnosis.
    Aggarwal N, Bhargava R, Elishaev E.
    Int J Gynecol Pathol; 2012 Sep 01; 31(5):447-52. PubMed ID: 22833085
    [Abstract] [Full Text] [Related]

  • 13. Atypical polypoid adenomyoma of the endometrium: diagnosis and treatment. A case report.
    Domeniconi L, Amadori A, Maniglio P, Saragoni L.
    Pathologica; 2020 Dec 01; 112(4):214-218. PubMed ID: 33393525
    [Abstract] [Full Text] [Related]

  • 14. Use of myocardin in the classification of mesenchymal tumors of the uterus.
    Liang J, Wu L, Xiao H, Li N, Wang H, Cheng C, Bai R, Zhao Y, Zheng H.
    Int J Gynecol Pathol; 2010 Jan 01; 29(1):55-62. PubMed ID: 19952936
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
    Nascimento AF, Hirsch MS, Cviko A, Quade BJ, Nucci MR.
    Mod Pathol; 2003 Jan 01; 16(1):22-7. PubMed ID: 12527709
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
    Zhao C, Bratthauer GL, Barner R, Vang R.
    Am J Surg Pathol; 2007 Sep 01; 31(9):1378-86. PubMed ID: 17721194
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.
    McCluggage WG, Connolly LE, McBride HA, Kalloger S, Gilks CB.
    Histopathology; 2012 Mar 01; 60(4):547-53. PubMed ID: 22250726
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.